INTERACTION OF DIAZEPAM OR LORAZEPAM WITH ALCOHOL - PSYCHOMOTOR EFFECTS AND BIOASSAYED SERUM LEVELS AFTER SINGLE AND REPEATED DOSES

被引:35
作者
ARANKO, K
SEPPALA, T
PELLINEN, J
MATTILA, MJ
机构
关键词
D O I
10.1007/BF00544067
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Healthy volunteers (9) in a double-blind, cross-over trial received diazepam (DZ) 10 mg, lorazepam (LZ) 2.5 mg, or placebo (P). Serum benzodiazepine (BZ) was bioassayed (radioreceptor method) and psychomotor tests were carried out on day 1 (before and 1 h after the 1st dose) and on day 4 (before and after the 5th dose). In each session alcohol 1 g/kg was administered 1.5 h after drug intake and the measurements were repeated twice. Serum BZ concentrations, expressed as DZ equivalents (.mu.g/l), ranged from 390-440 and 990-1240 measured 2 h 45 min after the 1st doses of DZ and LZ, respectively. On day 1 BZ alone impaired psychomotor skills. LZ affected performance more in objective tests, but DZ was subjectively rated as causing more drowsiness. After the intake of alcohol, all groups showed impairment in various tests. The rank order was LZ + alcohol > DZ + alchol > P + alcohol. Residual BZ activity on day 4, measured 18 h after the 4th dose, averaged 290 and 450 .mu.g/l after DZ and LZ, respectively. At the same time slight residual exophoria was found after both BZ. Tolerance to BZ on day 4 was unambiguous only when drug effects were related to the bioassayed serum levels. The combined action of BZ and alcohol was similar on days 1 and 4. A tendency to an increased drug-alcohol interaction during advanced treatment with DZ was seen in the body sway test. An attempt to clarify the very different serum BZ level after DZ and LZ was made in vitro by evaluating the displacement curves for DZ and LZ standards. The potencies of these BZ differed more in the presence than in the absence of serum. The psychomotor effects of DZ and LZ, as well as their BZ receptor occupation activity in serum, were not equipotent at doses 10 mg DZ and 2.5 mg LZ. The BZ-alcohol interaction was consistent at least over the first 5 doses.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 30 条
[1]  
AALTONEN L, 1982, ACTA PHARMACOL TOX, V50, P206
[2]  
AALTONEN L, 1980, ACTA PHARMACOL TOX, V46, P156
[3]   COMPARATIVE PROTEIN-BINDING OF DIAZEPAM AND DESMETHYLDIAZEPAM [J].
ALLEN, MD ;
GREENBLATT, DJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (5-6) :219-223
[4]  
ARANKO K, 1985, ACTA PHARMACOL TOX, V56, P364
[5]   DEVELOPMENT OF TOLERANCE AND CROSS-TOLERANCE TO THE PSYCHOMOTOR ACTIONS OF LORAZEPAM AND DIAZEPAM IN MAN [J].
ARANKO, K ;
MATTILA, MJ ;
SEPPALA, T .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (05) :545-552
[6]  
BENNETT J-P., 1978, NEUROTRANSMITTER REC, P57
[7]  
BO O, 1975, 6TH P INT C ALC DRUG
[8]   BRAIN SPECIFIC BENZODIAZEPINE RECEPTORS [J].
BRAESTRUP, C ;
SQUIRES, RF .
BRITISH JOURNAL OF PSYCHIATRY, 1978, 133 (SEP) :249-260
[9]   MEASUREMENT OF RECOVERY FROM OUTPATIENT GENERAL ANAESTHESIA WITH A SIMPLE OCULAR TEST [J].
HANNINGTONKIFF, JG .
BMJ-BRITISH MEDICAL JOURNAL, 1970, 3 (5715) :132-+
[10]  
HINDMARCH I, 1978, ARZNEIMITTEL-FORSCH, V28-2, P2357